State Of Tennessee, Treasury Department Amneal Pharmaceuticals, Inc. Transaction History

State Of Tennessee, Treasury Department

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$1.96 - $2.61 $204,218 - $271,943	104,193 New	104,193 $207,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $28,140 - $41,696	-9,349 Reduced 9.62%	87,871 $279,000
Q1 2022 May 11, 2022	BUY	$3.9 - $4.89 $127,323 - $159,643	32,647 Added 50.56%	97,220 $405,000
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $14,050 - $18,386	-3,260 Reduced 4.81%	64,573 $345,000
Q2 2021 Aug 11, 2021	BUY	$5.12 - $6.82 $65,582 - $87,357	12,809 Added 23.28%	67,833 $347,000
Q1 2021 May 10, 2021	BUY	$4.74 - $7.38 $125,041 - $194,684	26,380 Added 92.1%	55,024 $370,000
Q4 2020 Feb 09, 2021	BUY	$3.95 - $5.42 $113,143 - $155,250	28,644 New	28,644 $131,000

183

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.21B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

Stay updated on State Of Tennessee, Treasury Department with notifications on news.